PWP
REGN icon

Private Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Private Wealth Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.62M Sell
2,095
-175
-8% -$134K 0.12% 78
2025
Q4 		$1.75M Buy
+2,270
New +$1.54M 0.12% 74
2016
Q4 		– Sell
-500
Closed -$201K – 120
2016
Q3 		$201K Buy
+500
New +$201K 0.05% 115

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Private Wealth Partners's REGN Position: Q1 2026 in Review

Private Wealth Partners reduced its Regeneron Pharmaceuticals (REGN) stake by 7.7% in Q1 2026, selling an estimated $134K and leaving 2,095 shares worth $1.62M. The position accounts for 0.12% of the portfolio, ranked #78.

Private Wealth Partners first reported a position in REGN in Q3 2016 and has held it in 3 quarters since. The position peaked at $1.75M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Private Wealth Partners held 2,095 shares of Regeneron Pharmaceuticals worth $1.62M as of Q1 2026.
  • Private Wealth Partners sold 175 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $134K.
  • Regeneron Pharmaceuticals made up 0.12% of Private Wealth Partners's portfolio in Q1 2026, its #78 holding.
  • Private Wealth Partners first reported a position in Regeneron Pharmaceuticals in Q3 2016 and has held it in 3 quarters since.
  • Private Wealth Partners's Regeneron Pharmaceuticals position peaked at $1.75M in Q4 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Private Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.